Health Catalyst Q1 revenue up 8% to $73.9M, Adj. EBITDA $4.2M beats guidance; expands Allina Health pact

Health Catalyst, Inc.

2023-Q1 EPS reported -$0.60 revenue$73,868,000

Total revenue $73.9M (+8% YoY); Technology revenue $47.2M (+12%), Professional services $26.7M (+3%).
GAAP net loss $33.2M (widened 48% YoY); Adjusted EBITDA $4.2M (up 521%, above guidance midpoint).
Expanded tech-enabled managed services partnership with Allina Health; recurring revenue now ~$11M/year.
Adjusted Technology Gross Margin 70% (flat); Adjusted Professional Services Gross Margin fell to 20% from 29%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Health Catalyst, Inc. reported the quarter ended March 31, 2023 results: revenue $73,868, net income $(33,190).

Period: the quarter ended March 31, 2023
Revenue: $73,868
Net income: $(33,190)
Result: reported results

Exact text from the filing

GAAP Financial Data: (in thousands, except percentages, unaudited) Technology revenue $ 47,186 $ 42,230 12% Professional services revenue $ 26,682 $ 25,857 3% Total revenue $ 73,868 $ 68,087 8% Loss from operations $ (34,914) $ (24,347) (43)% Net loss $ (33,190) $ (22,458) (48)% Other Non-GAAP Financial Data: (1) Adjusted Technology Gross Profit $ 32,958 $

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Health Catalyst, Inc. filing history →

Source: SEC EDGAR

accession 0001636422-23-000056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.